IP Library Granted Patent US 7,303,869
Granted Patent B2
US 7,303,869 · App. 10/269,222 · Granted Dec 4, 2007

Solid-phase reactions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,303,869
App. No.
10/269,222
Granted
Dec 4, 2007
Kind
B2
Abstract

The present invention relates to systems, compositions, and methods for the detection and characterization of nucleic acid sequences and variations in nucleic acid sequences. The present invention relates to methods for attaching nucleic acids to solid supports and modifying nucleic acids. For example, in some embodiments, the 5′ nuclease activity of a cleavage agent is used to cleave a cleavage structure formed on the solid support, the occurrence of the cleavage event indicating the presence of specific nucleic acid sequences.

Claims (21)

1. A method for detecting polymorphisms in unamplified DNA, comprising:

a. providing:

i. unamplified genomic DNA, wherein said unamplified genomic DNA comprises 50 micrograms or less of genomic DNA;

ii. a microsphere;

iii. oligonucleotides and enzymes for conducting an invasive cleavage reaction, wherein said oligonucleotides comprise a probe oligonucleotide and an upstream oligonucleotide each attached to said microsphere via a spacer molecule, wherein said spacer molecule has a length of 10 hexaethylene glycol molecules and, wherein said upstream oligonucleotide is configured to hybridize to a target sequence in a manner that overlaps with said probe oligonucleotide; and

b. treating said unamplified genomic DNA with said oligonucleotides and enzymes under conditions such that said upstream oligonucleotide and said probe oligonucleotide hybridize to said unamplified genomic DNA such that said upstream oligonucleotide overlaps said probe oligonucleotide, and an invasive cleavage reaction occurs on said microsphere such that the presence or absence of a polymorphism in said unamplified genomic DNA is identified.

2. The method of claim 1 , wherein said oligonucleotides and enzymes are configured to detect a plurality of different polymorphisms in said unamplified genomic DNA.

3. The method of claim 2 , wherein said plurality of different polymorphisms comprises at least 100 different polymorphisms.

4. The method of claim 2 , wherein said plurality of different polymorphisms comprises at least 1000 different polymorphisms.

5. The method of claim 2 , wherein said plurality of different polymorphisms comprises at least 1,000,000 different polymorphisms.

6. The method of claim 1 , wherein said treating step is carried out in a single reaction vessel.

7. The method of claim 1 , wherein said oligonucleotides and enzymes are present in approximately equal concentrations.

8. The method of claim 1 , wherein said treating comprises use of flow cytometry.

9. A method for detecting polymorphisms in unamplified DNA, comprising:

a. providing:

i. unamplifled genomic DNA, wherein said unamplified genomic DNA comprises 50 micrograms or less of genomic DNA;

ii. a solid surface;

iii. oligonucleotides and enzymes for conducting an invasive cleavage reaction, wherein said oligonucleotides comprise a probe oligonucleotide and an upstream oligonucleotide each attached to said solid surface via a spacer molecule, wherein said spacer molecule has a length of 10 hexaethylene glycol molecules, and wherein said upstream oligonucleotide is configured to hybridize to a target sequence in a manner that overlaps with said probe oligonucleotide;

iv. a flow cytometer;

b. treating said unamplified genomic DNA with said oligonucleotides and enzymes under conditions such that said probe oligonucleotide and said upstream oligonucleotide hybridize to said unamplified genomic DNA such that said upstream oligonucleotide overlaps said probe oligonucleotide, and an invasive cleavage reaction, occurs on said solid surface such that a signal is generated, said signal indicating the presence or absence of said polymorphism; and

c. detecting said signal with said flow cytometer.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
NUNC PRO TUNC ASSIGNMENT Recorded Mar 23, 2009
From: NORTHWESTERN UNIVERSITY
To: THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 022427/0781 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2003
From: STEVENS, PRISCILLA WILKINS; KELSO, DAVID; LYAMICHEV, VICTOR; HALL, JEFF; NERI, BRUCE P.; KWIATKOWSKI, ROBERT W. JR.; SMITH, LLOYD M.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 013747/0807 →